Luton, Bedfordshire, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The global cardiac device market is experiencing tremendous growth. This is driven by the increasing prevalence of chronic heart ...

Cardio-kidney-metabolic (CKM) syndrome is a term to describe the interconnection between cardiovascular disease, type 2 diabetes, and chronic kidney disease. The National Health and Nutrition ...

In a recent review published in the Canadian Journal of Cardiology, researchers discussed the association between cardiovascular health and the exposome, which comprises the cumulative impact of ...

Cardiovascular (CV) disease is commonly observed in individuals with type 2 diabetes (T2D) and is associated with significant morbidity and mortality. Diabetes medications can have substantial ...

Please provide your email address to receive an email when new articles are posted on . Delve into the cutting-edge world of Cardiovascular-Kidney-Metabolic (CKM) Syndrome management in this CKM ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Despite updated treatment guidelines, a prevalent gap ...

As new therapies improve survival from cancer, attention to comorbid illness and complications of therapy—both short- and long-term—become much more important to improving not only quality of life but ...

Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled A Master ...

Cardiovascular disease (CVD) is the leading cause of death and a major cause of disability worldwide. In the United States, CVD accounted for 34.4 percent of the 2.4 million deaths in 2003 and remain ...